CANONSBURG, PA – JULY 14: Mylan headquarters stands July 14, 2014 in Canonsburg, Pennsylvania The generic drugmaker Mylan is buying Abbott Laboratories’ generic-drugs business in developed markets for stock valued at about $5.3 billion. (Photo by Jeff Swensen/Getty Images)